| Tag | Content |
|---|
EnhancerAtlas ID | HS019-00291 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr1:26034660-26036460 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESR1 | MA0112.3 | chr1:26034959-26034976 | AAGGTCTTTGTGACCTG | - | 6.09 | | ESR2 | MA0258.2 | chr1:26034960-26034975 | AGGTCTTTGTGACCT | - | 6.63 | | SRF | MA0083.3 | chr1:26034762-26034778 | AGACCATATATGGTAA | + | 7.54 | | SRF | MA0083.3 | chr1:26034762-26034778 | AGACCATATATGGTAA | - | 7.72 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_38954 | chr1:26034782-26036344 | IMR90 | | SE_41438 | chr1:26032525-26036004 | Left_Ventricle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I025706 | chr1 | 26032657 | 26039065 |
|
Enhancer Sequence | ACAGTTATTT CTTGACCATA TGCTAAACAA GGGATGGATT ATTCATGAGT TTTCCAGGGA 60
AGGGGTGGGC AATTCCCTGA ACTGAGGGTT CCTCCCTTTT TTAGACCATA TATGGTAACT 120
TCCTGATGTT GCCATGGCAT TTATAAATAG TCATGGCGCT GGTGGGAGTG CCTTTTAGCA 180
TGCTAATATA TTATAATTAG TGCCTAATGA GCAATGAGGA CAATGGGAGG TCACTTTCAT 240
CACCATCTTG GTTTTTGTGG GCTTTGGCCA GCTTCTTTAC CATAGCCTGT TTTATCAGCA 300
AGGTCTTTGT GACCTGTATC TTCAGCTACC CCCGCCCATC TCATCCTGTG ACTAAGAATG 360
CCTAACCTCC TGGGAATGCA GCCCAGTAGG TCTCAGCTTC ATTTTACCCA GTCCCTATTC 420
AAGATGGAGT TGCAGCCAGG CACAGTGGCT CATGCCTGTA ATCCCAGCAC TTTGGGAGGC 480
CGAGGCAGGC GGATCACCTG AGGTCAGGAG TTTGAGACCA GCCTGGGCAA CGTGGAGAAA 540
TCCTGTCTCT ACTGAAAATA CAAAAATTAG TTGGGCAGTT GCTGCGCTCC TGTAATCCCA 600
GCTACTTGGG AGACTGAGGC AGGAGAATCA CTTGAACCTG GGAGGTGGAG GTTGCAGTGA 660
GCTGAGATTG CACCACTGCA CTCCAGCCTG GGCAACAAGA GCGAAACGCT GTCAAAAGAA 720
GAAAAAAAAA AGCCACTGGC TTGGAAAGTA TCTGAGAAAG TCCCTGGTAA ATTTCATTCC 780
ACTCCAACTG GGGTCTTGGC ACTTGCATTT TCCTGAGCCC AGCCCCAGGG ACCGCAGGAA 840
TCCATACATC TGCAGGGATG AGACACAGCC GATGCCCACC GCCATGCAGA AGCCTAACAC 900
CTACTAGGCT GAAAGTCACC CCAGGGCACT AAGCCAGGGA GGGTTGAAGG GGGTGGAAGA 960
TCATCAGGGA GAGAGTAGGT TTTCCTATTT GAGAAGTGAA AGGCGGTATA GACGGCTGTC 1020
CTCCATGCCT TGGATTGTAG GTGGCATTTA CTGCTCAAGG AGAAGGGACA CTCAGAGACC 1080
TGATGCAGAA CACGGAGGAG GCAGTAAGAC CGGCTAAGCT AGGTGAGTTT AGGAAAGTCC 1140
AGCAGGGCCA CCTACTTATT TTGCAGTCAT AAAAACAGCA GCTCCAGGCC CTCAATGCTG 1200
GCATGTAGTA GGTACTCAAT AAATGTCTGC AGAAGCAATG AATGAGTCCT GTCAAAAGTA 1260
ACAGTACTGA ATCAAACCAG TGTTCTGGGA GGCAGGCACG CAGATGTTTC TTGTCCACCC 1320
TAACTCTCCA GCTCCAAAGC CCATGCTCTT ACCCAGGGCT CTGTGAGCCC TATTCAGTTG 1380
TGTTAATCAG ATGTGGCTGC ATTGCCTCCC CGCCGTCTTG GTTACAGTAA ATGTCCTTTA 1440
AGTTGCAAGG GCCTGGGGTG GCAGGGGTAG AGGAATGCAT GAAGATTCCT CACCAATGCC 1500
TGATACTGTC AGTCTTCGTA ACGTTAGCCT TTCTAGCAGA AGGAAACTCT ATCTATCTAT 1560
CTATCTATCT ATATTTATTT ATTTTATTTT TTTGAGATGG AGTCTCACTC TTGTCGCCCA 1620
GACTGGAGTG CAGTGGCATA GTCTCGGCTC ACTGCAACTT CTGCCTCCCG GGTTCAAGCG 1680
ATTCTCCTGC CTCAGCCTCC CGAGTAGCTA GGATTACAGG CGCCCGCAAC CACGCCCAGC 1740
TAATTTTTGT ATTTTTAGTA GAGACAGGGT TTCACTGTGT TGGCCAGGCT GGTCTCGAAC 1800
|
